Debreczeni L A, Farsang C, Takács L
Acta Physiol Acad Sci Hung. 1980;56(4):341-65.
Effects of phenoxybenzamine (1 mg per 100 g i.v.), propranolol (0.2 mg per 100 g i.v.), phenylephrine (0.1--0.3--1.0--3.0 micrograms per 100 g per min) and isoproterenol (0.01--0.03--0.1--0.3 micrograms per 100 g per min) were studied on cardiac output (Evans-blue dilution), organ and tumour blood flows (Sapirstein's isotope indicator dilution technique) in rats bearing Guérin carcinoma. In agreement with our earlier results data for haematocrit, blood pressure, TPR and organ vascular resistance were lower whereas cardiac index and organ blood flow were higher in control untreated tumour-bearing animals than in untreated normal rats. Phenoxybenzamine, depending on tumour size, decreased blood pressure, TPR and vascular resistance of organs, while it was found ineffective in rats with tumours of very large size (60--80 g). Propranolol treatment produced slight and similar effects in both normal and tumour-bearing rats. Phenylephrine enhanced peripheral resistance as a function of log dose in both normal and tumour bearing animals, nevertheless in the latter group it elicited more marked responses in the vascular bed of the kidneys, intestines and skin. The vasodilatory log dose dependent effect of isoproterenol was not present in tumour-bearing rats. In addition to the anaemia, the continuous decrease of alpha adrenergic activity in the systemic circulation parallel with tumour growth appears to be the most reasonable explanation for the "hyperkinesis" observed in tumour-bearing rats. Resistance of tumour vascular bed was increased by both phenoxybenzamine and propranolol. During the course of phenylephrine infusion (1.0 or 3.0 micrograms per min) the resistance of tumour vessels was more increased than that of other organs. Isoproterenol infusion resulted in a vasoconstriction of the tumour vessel. It appears that with maximally dilated vessels, vasoconstriction remains the only possible vascular response in Guérin carcinoma. In the vascular bed of the tumour a preponderance of beta adrenergic receptors also seems to be feasible.
研究了苯氧苄胺(静脉注射,每100克1毫克)、普萘洛尔(静脉注射,每100克0.2毫克)、去氧肾上腺素(每100克每分钟0.1 - 0.3 - 1.0 - 3.0微克)和异丙肾上腺素(每100克每分钟0.01 - 0.03 - 0.1 - 0.3微克)对荷Guérin癌大鼠的心输出量(伊文思蓝稀释法)、器官及肿瘤血流量(Sapirstein同位素指示剂稀释技术)的影响。与我们早期的结果一致,与未处理的正常大鼠相比,未处理的荷瘤动物的血细胞比容、血压、总外周阻力(TPR)和器官血管阻力数据较低,而心脏指数和器官血流量较高。苯氧苄胺根据肿瘤大小降低血压、TPR和器官血管阻力,但在肿瘤非常大(60 - 80克)的大鼠中发现其无效。普萘洛尔治疗在正常大鼠和荷瘤大鼠中产生轻微且相似的效果。去氧肾上腺素在正常动物和荷瘤动物中均随对数剂量增加外周阻力,然而在后者组中,它在肾脏、肠道和皮肤的血管床中引起更明显的反应。异丙肾上腺素的血管舒张对数剂量依赖性效应在荷瘤大鼠中不存在。除贫血外,全身循环中α肾上腺素能活性随肿瘤生长持续降低似乎是荷瘤大鼠中观察到的“运动亢进”的最合理原因。苯氧苄胺和普萘洛尔均增加肿瘤血管床的阻力。在输注去氧肾上腺素(每分钟1.0或- 3.0微克)过程中,肿瘤血管的阻力比其他器官增加得更多。输注异丙肾上腺素导致肿瘤血管收缩。似乎在血管最大程度扩张的情况下,血管收缩仍然是Guérin癌唯一可能的血管反应。在肿瘤的血管床中,β肾上腺素能受体占优势似乎也是可行的。